Suzanne Lepage

Severe asthma is a complex condition that impacts between 150,000 and 250,000 Canadians, according to Vanessa Foran, president and chief executive officer of Asthma Canada, during a webinar hosted last month by Benefits Canada and supported by AstraZeneca. It’s an acute condition where people have difficulty achieving control of their disease despite proper use of […]

  • July 6, 2022 August 15, 2022
  • 09:00

A British Columbia labour arbitration decision is providing insight on how a block level implementation of a benefits provider’s drug cost-control program violated a collective agreement in a unionized workplace. The Douglas College Faculty Association grieved the implementation of Manulife’s DrugWatch program contravened their collective agreement, which ensured “there will be no change to the […]

  • May 16, 2022 May 17, 2022
  • 09:00

A migraine attack is much more severe than a headache because it comes with a lot of other symptoms, according to Dr. Elizabeth Leroux, a neurologist, president of the Canadian Headache Society and chair of Migraine Canada, speaking during a session supported by Abbvie at Benefits Canada‘s Chronic Disease at Work event in February. Migraine, […]

  • March 7, 2022 March 3, 2022
  • 07:59

“Diabetes is a disease that you do not see from the outside,” said Kayla O’Connell, who lives with type 1 diabetes and is a sales support associate at Medtronic, during a session at Benefits Canada‘s 2022 Chronic Disease at Work event in February. About 10 per cent of Canadians with diabetes have type 1, while […]

  • March 7, 2022 March 3, 2022
  • 07:57

The burden of musculoskeletal disease has had a significant impact on the lives of Canadians at home and at work, said Alison Dantas, chief executive officer at Canadian Chiropractic Association during Benefits Canada‘s 2022 Chronic Disease at Work event in February. According to the World Health Organization, musculoskeletal conditions are the leading cause of disability around […]

  • March 7, 2022 March 3, 2022
  • 07:55

Musculoskeletal issues have a far-reaching impact on the mental, physical and emotional wellness of benefits plan members and their families — however, they also come at a cost to plan sponsors. According to Sun Life Assurance. Co.’s 2020 disability claims, 20 per cent were related to musculoskeletal health conditions and 30 per cent of these affected […]

  • March 7, 2022 March 3, 2022
  • 07:54

While about a million Canadians live with psoriasis, one in three will go on to develop psoriatic arthritis, said Rachael Manion, executive director of the Canadian Association of Psoriasis Patients and the Canadian Skin Patient Alliance, during a session supported by UCB Canada Inc. at Benefits Canada‘s 2022 Chronic Disease at Work event in February. Psoriasis […]

  • March 7, 2022 March 7, 2022
  • 07:50

While there’s a 2.5 per cent lifetime chance of having alopecia areata, the progression can be unpredictable and cause a lot of stress for patients, according to Dr. Lyn Guenther, professor of dermatology at Western University, during a webinar hosted by Benefits Canada and supported by Pfizer earlier this month. Alopecia areata is more than […]

  • February 1, 2022 February 3, 2022
  • 09:00

The drug pipeline is full of new medications that may be more effective but may also be more expensive than existing treatments. Although they could significantly improve a benefits plan member’s health, they could also render a plan unaffordable. “Because drugs represent a significant portion of group insurance plan costs, plan sponsors are concerned about […]

  • January 24, 2022 January 24, 2022
  • 07:58

The coronavirus pandemic and the changing environment have impacted pharmaceutical manufacturer-sponsored patient support programs. Manufacturers offer patient support programs to help individuals access their medication and navigate the health-care system, according to Sandra Anderson, senior vice-president of commercialization and strategy at Innomar Strategies, speaking during a session at Benefits Canada‘s Face to Face in Drug […]

  • January 24, 2022 January 24, 2022
  • 07:57